Connect with us

Diagnosis

Home urine tests could detect breast cancer, endometriosis and PCOS

Published

on

“Game-changing” home urine tests to detect early stage breast cancer are being developed in Wales, alongside similar work on endometriosis and polycystic ovary syndrome.

Researchers said they hope to have a prototype kit within the next year to detect early stage breast cancer using a lateral flow urine sample. Lateral flow tests are simple strip-based devices used during the Covid-19 pandemic.

A similar test is now also being explored for endometriosis and polycystic ovary syndrome, or PCOS, which in the long term could help reduce diagnostic waiting times.

The developments form part of wider work on women’s health in Wales, with women’s health hubs being rolled out across all parts of the country.

The research is being led by Prof Luis Mur at Aberystwyth University, who said key changes could be identified in urine to detect breast cancer “with a high degree of accuracy” and that new at-home tests were being developed to complement existing diagnostic tools.

“We’ve found very important changes in urine to tell you’ve got breast cancer, and even [which] stage of breast cancer,” he said.

“We’re building little kits that are based on urine that actually allow you to go to your GP and have it done, or even do it at home.”

Mur said it could take about 18 months to develop the lateral flow prototypes, followed by a further three to five years of testing to confirm accuracy.

“We need to have 90 per cent accuracy or greater, at the moment we’ve got it, but we need to make sure we get that with the kit itself,” he said.

He added that researchers were now applying the same approach to detect endometriosis and PCOS, where “diagnoses are very poor and also very delayed”.

The breast cancer testing kits are among projects funded by the Welsh government’s £75m investment in women’s health research, as part of the women’s health plan.

Dr Helen Munro, clinical lead for women’s health in Wales, said one of the goals of the Women’s Health Research Centre was to bring research findings, such as the work at Aberystwyth University, into clinical practice “in a timely way”.

“Currently there’s evidence to suggest it takes 17 years for evidence to get into practice, Munro said.

“But what we’re doing in Wales is working really closely with our academic universities and health boards to shorten that gap.”

The 10-year women’s health plan in Wales, published in December 2024, also set out ambitions for women’s health hubs in each health board.

By the end of this month each health board will have at least one hub serving part of their community, though Munro said “each will look different”.

In west and mid Wales, Hywel Dda health board has split the region into seven GP clusters, each of which will have a women’s health service.

GPs in each cluster have been trained to provide menopause and contraceptive care and can take referrals from other surgeries, bringing specialist care closer to home.

“We’re aiming to see a reduction in referrals into secondary care, with women referred into the hub in a timelier fashion,” said Dana Scott, who is leading the women’s health plan for Hywel Dda.

Dr Lauren Thomas, a sexual health doctor who has been training GPs in more remote areas to fit coils and contraceptive implants, said ultrasound biopsies would also be available in each county.

“As a GP I see women wait months and months and months to see gynae [specialists] because obviously the secondary care service has to prioritise suspected cancer cases,” she said.

“Women are left with pelvic pain or [with] endometriosis waiting a long time for discussions, investigations and treatments that they could access in a community-based clinic, and hopefully we’ll be able to bring that to women moving forward.”

Munro said all hubs had been asked to deliver on three priority areas: menopause care, contraception and pelvic health.

Sarah Murphy MS, minister with responsibility for women’s health, said each health board was “starting from different places”.

She said: “They’re trying to fill in the gaps, breaking down the barriers for each of those locations and communities.

“But as we go forward there’ll be an evaluation and we’ll spread that good practice across Wales.”

Diagnosis

WHO launches AI tool for reproductive health information

Published

on

The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster.

Called ChatHRP, the tool was created by WHO’s Human Reproduction Programme and draws only on verified research and guidance collected by HRP and WHO.

It uses natural language processing and retrieval-augmented generation to produce referenced content and cut the time spent searching through documents across different platforms and databases.

WHO said ChatHRP also has multilingual capabilities and low-bandwidth functionality to support use in a wide range of settings.

The beta-testing phase is aimed at a broad professional audience, including policymakers, healthcare workers, researchers and civil society groups.

WHO said the tool can help users quickly access up-to-date evidence, find sources for academic work and verify information on sexual and reproductive health and rights.

Examples of questions it can answer include the latest violence against women data in Oceania for women aged 15 to 49, recommendations on managing diabetes during pregnancy, and whether PrEP and contraception can be used at the same time. PrEP is medicine used to reduce the risk of getting HIV.

WHO added that the system will be updated regularly as new HRP materials are published and includes a feedback loop so users can flag gaps in the information provided.

The launch comes amid wider concern about misinformation in sexual and reproductive health.

A 2025 scoping review found that misinformation in digital spaces is a systemic issue that can undermine human rights, reinforce discriminatory social norms and exclude marginalised voices.

The review also said misinformation can affect health systems by shaping provider knowledge and practice, disrupting service delivery and creating barriers to equitable care.

WHO said ChatHRP is intended to give users streamlined access to reliable information as a counter to “algorithms, opinions, or misinformation”.

Continue Reading

Menopause

AI maps how reproductive organs age differently during menopause

Published

on

An AI atlas has mapped how reproductive organs age through menopause, with the ovaries, vagina and uterus changing on different timelines.

To better understand how this process affects health, researchers at the Barcelona Supercomputing Center developed what they describe as the first large-scale atlas of female reproductive system ageing, using artificial intelligence.

The team combined 1,112 tissue images from 659 samples, covering 304 women aged 20 to 70, with gene expression data from thousands of genes.

This allowed them to reconstruct how seven key reproductive organs, including the uterus, ovary, vagina, cervix, breast and fallopian tubes, age over time.

The study used the supercomputing power of MareNostrum 5 together with advanced image-recognition methods to process the data.

Using deep learning techniques, the researchers detected visible tissue changes as well as the underlying molecular processes linked to ageing in each organ.

The result was a detailed, organ-by-organ map of the reproductive system’s ageing process.

The researchers found that not all organs age in the same way or at the same speed. The ovaries and vagina showed a more gradual ageing process that begins even before menopause officially starts.

By contrast, the uterus appeared to undergo more sudden changes around the time of menopause.

Even within a single organ, different tissues aged at different rates. In the uterus, for example, the mucosa, its inner lining, and the muscular layer did not change in sync. These tissues also appeared to be particularly sensitive to the hormonal and biological shifts associated with menopause.

Marta Melé, leader of the transcriptomics and functional genomics group at BSC and director of the study, said: “Our results show that it acts as a turning point that profoundly reorganises other organs and tissues of the reproductive system, and allows us to identify the genes and molecular processes that could be behind these changes.”

Building on the finding that organs age according to different patterns, co-first author Laura Ventura said the research “paves the way for personalised medicine where treatments are tailored to a woman’s specific molecular profile and the specific tissues showing the most age-related distress.”

The study also identified molecular signals linked to reproductive ageing that can be detected in blood samples from more than 21,441 women.

These biomarkers could allow doctors to monitor the condition of reproductive organs in a non-invasive way, potentially helping to anticipate risks such as pelvic floor complications without the need for biopsies.

According to the researchers, this could lead to simpler and more accessible clinical tools for tracking women’s health over time.

Continue Reading

Pregnancy

Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds

Published

on

Early miscarriage care after a first loss could prevent about 10,000 pregnancy losses a year in the UK, according to a new study.

The study by Tommy’s National Centre for Miscarriage Research and Birmingham women’s hospital involving 406 women found a 4 per cent reduction in the risk of future miscarriage for women on the graded model of care compared with usual care.

Women in England, Wales and Northern Ireland currently become eligible for specialised NHS care for early baby loss only after they have had at least three miscarriages.

Tommy’s has called for women to become eligible after one miscarriage, saying this could reduce the risk of future miscarriages and improve health outcomes for mothers.

Researchers said that would translate to 10,075 fewer miscarriages a year across the UK.

Kath Abrahams, chief executive of Tommy’s, said women were being “left without early access to services that could help prevent future losses and reduce the debilitating feelings of isolation and hopelessness that we know affect so many who experience pregnancy loss”.

She said: “Our pilot study indicates that providing support after a first miscarriage, with escalating care after further losses, is not only effective but achievable without significant additional workload for NHS teams who are already working extremely hard to deliver good care.

“Put simply, it is the right thing to do. We will do all we can to drive that change across the UK so that more women and families are supported after every miscarriage.”

The graded model of miscarriage care proposed by Tommy’s is already available in Scotland, and the charity is calling for it to be introduced across the whole of the UK.

The graded model includes nurse-led support after one miscarriage, with advice on reducing risk factors such as low vitamin D, folic acid intake, alcohol consumption and caffeine use.

Women who received the specialised care were 47 per cent more likely to have a risk factor identified and receive relevant advice to help prevent future miscarriages than women receiving usual care, the study found.

Among women who had experienced two miscarriages and received the specialised care, one in five were found to have thyroid dysfunction or anaemia, both conditions that can affect pregnancy outcomes.

About one in four pregnancies ends in miscarriage, most often within the first 12 weeks of pregnancy.

The report comes ahead of the long-awaited final findings of the government’s investigation into maternity care in England. Interim findings uncovered a range of failures, including claims that NHS hospitals that caused harm to women and babies during childbirth often resorted to a “cover-up” of their mistakes, falsified medical records and denied bereaved parents answers.

Women’s health minister Gillian Merron said: “Pregnancy and baby loss can have a devastating impact on women and families, who too often feel they have been left without the care and support they need.

“I welcome the findings of this important report, and this will be carefully considered as part of our ongoing work to make sure women get the high-quality, compassionate NHS care they deserve.”

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.